Garrison Bradford & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-4,000
| Closed | -$241K | – | 57 |
|
2020
Q3 | $241K | Hold |
4,000
| – | – | 0.34% | 40 |
|
2020
Q2 | $235K | Hold |
4,000
| – | – | 0.34% | 42 |
|
2020
Q1 | $223K | Hold |
4,000
| – | – | 0.38% | 39 |
|
2019
Q4 | $257K | Hold |
4,000
| – | – | 0.32% | 42 |
|
2019
Q3 | $203K | Buy |
+4,000
| New | +$203K | 0.28% | 47 |
|
2019
Q1 | – | Sell |
-4,000
| Closed | -$208K | – | 83 |
|
2018
Q4 | $208K | Hold |
4,000
| – | – | 0.19% | 65 |
|
2018
Q3 | $248K | Hold |
4,000
| – | – | 0.2% | 59 |
|
2018
Q2 | $221K | Hold |
4,000
| – | – | 0.18% | 63 |
|
2018
Q1 | $253K | Hold |
4,000
| – | – | 0.22% | 57 |
|
2017
Q4 | $245K | Hold |
4,000
| – | – | 0.2% | 63 |
|
2017
Q3 | $255K | Hold |
4,000
| – | – | 0.21% | 62 |
|
2017
Q2 | $223K | Hold |
4,000
| – | – | 0.19% | 64 |
|
2017
Q1 | $218K | Hold |
4,000
| – | – | 0.19% | 66 |
|
2016
Q4 | $234K | Hold |
4,000
| – | – | 0.22% | 61 |
|
2016
Q3 | $216K | Hold |
4,000
| – | – | 0.2% | 67 |
|
2016
Q2 | $294K | Hold |
4,000
| – | – | 0.29% | 55 |
|
2016
Q1 | $256K | Hold |
4,000
| – | – | 0.3% | 53 |
|
2015
Q4 | $275K | Hold |
4,000
| – | – | 0.31% | 56 |
|
2015
Q3 | $237K | Hold |
4,000
| – | – | 0.26% | 66 |
|
2015
Q2 | $266K | Hold |
4,000
| – | – | 0.26% | 69 |
|
2015
Q1 | $258K | Hold |
4,000
| – | – | 0.24% | 74 |
|
2014
Q4 | $236K | Hold |
4,000
| – | – | 0.21% | 81 |
|
2014
Q3 | $205K | Buy |
+4,000
| New | +$205K | 0.21% | 88 |
|
2014
Q2 | – | Sell |
-4,000
| Closed | -$208K | – | 110 |
|
2014
Q1 | $208K | Hold |
4,000
| – | – | 0.2% | 93 |
|
2013
Q4 | $213K | Buy |
+4,000
| New | +$213K | 0.2% | 89 |
|